Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 12.10.2026 1 Am J Gastroenterol 5 Biochem Biophys Res Commun 4 BMC Gastroenterol 1 Cancer Res 1 Eur Radiol 3 Gut 1 Hepatology 2 J Gastroenterol Hepatol 1 J Hepatol 1 J Pediatr Surg 1 Oncogene 5 PLoS One 1 Proc Natl Acad Sci U S A 3 Radiology 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. TAPPER EB, Kardashian A, Debes J, Gripshover J, et al
   ACG Clinical Guideline: Preventive Care for Patients With Cirrhosis.
   Am J Gastroenterol. 2026 Oct 5. doi: 10.14309/ajg.0000000000004186.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. JAIN R, Puri V, Mungamuri SK, Garg P, et al
   Integrative predictive modelling and multi-omics validation reveals potential indicators of clinical heterogeneity in HCC.
   Biochem Biophys Res Commun. 2026;837:154590.
   PubMed         Abstract available
   
   
3. QIANG Z, Qin K, Zhou Y, Huang T, et al
   Dicoumarol suppresses intrahepatic cholangiocarcinoma growth via modulation of the PI3K/Akt signaling pathway.
   Biochem Biophys Res Commun. 2026;839:154686.
   PubMed         Abstract available
   
   
4. LIU M, Liu Z, Leng Y, Zhang Q, et al
   ZSP1601 is a non-selective phosphodiesterase inhibitor and a clinical drug candidate for the oral treatment of metabolic dysfunction-associated steatohepatitis.
   Biochem Biophys Res Commun. 2026;839:154684.
   PubMed         Abstract available
   
   
5. BI J, Sun K, Wu H, Chen X, et al
   Corrigendum to "PPARgamma alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway" [Biochem. Biophys. Res. Commun. 498, (2018), 1037-1044].
   Biochem Biophys Res Commun. 2026;837:154653.
   PubMed        
   
   
6. LUO H, Yang Y, Wen J, Hou Y, et al
   Mitophagy-related gene signatures predict prognosis and therapeutic response in hepatocellular carcinoma.
   Biochem Biophys Res Commun. 2026;838:154646.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. AWAIS AM, Das V, Wassam M, Mahsud NJ, et al
   Temporal trends and demographic disparities in mortality with co-mention of chronic liver disease and pneumonia in the United States, 1999-2024.
   BMC Gastroenterol. 2026;26:623.
   PubMed         Abstract available
   
   
8. WEISNER L, Wehmeyer M, Sebode M, Schulze Zur Wiesch J, et al
   Superior diagnostic yield of mini-laparoscopy over transjugular liver biopsy in acute-on-chronic liver failure: a case-control study.
   BMC Gastroenterol. 2026;26:616.
   PubMed         Abstract available
   
   
9. BAGHERI H, Seighali N, Gholami-Chahkand MS, Bakhtiyari M, et al
   Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study.
   BMC Gastroenterol. 2026;26:608.
   PubMed         Abstract available
   
   
10. XIONG XS, Cheng FZ, Qi WN, Cheng J, et al
    Association between the TyG/HDL-C ratio and non-alcoholic fatty liver disease: a single-centre retrospective study.
    BMC Gastroenterol. 2026;26:626.
    PubMed         Abstract available
    
    

    
    Cancer Res

11. GUO Z, Li Z, Lei T, Ren Y, et al
    ANXA1 Promotes Endoplasmic Reticulum-Mitochondria Calcium Coupling to Sustain Lenvatinib Resistance in Hepatocellular Carcinoma.
    Cancer Res. 2026 Oct 8. doi: 10.1158/0008-5472.CAN-26-2074.
    PubMed         Abstract available
    
    

    
    Eur Radiol

12. PARK J, Lim GS, Ko Y, Shin H, et al
    Preoperative radioembolization versus chemoembolization and upfront resection for resectable hepatocellular carcinoma beyond the Milan criteria.
    Eur Radiol. 2026 Oct 7. doi: 10.1007/s00330-026-12920.
    PubMed         Abstract available
    
    

    
    Gut

13. LIEBE R, Lammert F, Schmidt HH, Krawczyk M, et al
    Use of genetic analysis in adult cholestatic liver disease: lessons from progressive paediatric syndromes and cohort studies.
    Gut. 2026 Jun 17:gutjnl-2025-337027. doi: 10.1136/gutjnl-2025-337027.
    PubMed         Abstract available
    
    
14. CHEN Y, Jin GW, He LH, Dong Y, et al
    MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogramming.
    Gut. 2026 Feb 9:gutjnl-2025-336323. doi: 10.1136/gutjnl-2025-336323.
    PubMed         Abstract available
    
    
15. BEN KHALED N, Enssle S, Ricke J, Mayerle J, et al
    Rapid muscle loss beyond the transplant waiting list: outcomes in immunotherapy-treated hepatocellular carcinoma.
    Gut. 2026 Oct 7:gutjnl-2026-340713. doi: 10.1136/gutjnl-2026-340713.
    PubMed        
    
    

    
    Hepatology

16. WANG K, Du M
    Deciphering the post-transcriptional code in tumor progression: CPEB3 links genetic variation to alternative polyadenylation in hepatocellular carcinoma.
    Hepatology. 2026 Oct 7. doi: 10.1097/HEP.0000000000001882.
    PubMed        
    
    

    
    J Gastroenterol Hepatol

17. HUANG CF, Liang PC, Huang CK, Stec M, et al
    The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE-B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B.
    J Gastroenterol Hepatol. 2026 Oct 8. doi: 10.1111/jgh.70792.
    PubMed         Abstract available
    
    
18. HONMA Y, Shimose S, Ito T, Saeki I, et al
    Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab.
    J Gastroenterol Hepatol. 2026 Oct 5. doi: 10.1111/jgh.70793.
    PubMed         Abstract available
    
    

    
    J Hepatol

19. CHAN SL, Kudo M, Sangro B, Kelley RK, et al
    First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.
    J Hepatol. 2026 Oct 6:S0168-8278(26)02919-3. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

20. PEDERIVA F, Gentilino V, Bonanno C, Bertelli E, et al
    CONGENITAL HEPATOPULMONARY FUSION IN RIGHT CONGENITAL DIAPHRAGMATIC HERNIA: SURGICAL STRATEGY AND OUTCOMES IN A MULTICENTER COHORT.
    J Pediatr Surg. 2026 Oct 7:163521. doi: 10.1016/j.jpedsurg.2026.163521.
    PubMed         Abstract available
    
    

    
    Oncogene

21. TANG Q, Slarve I, Chen J, Zeng N, et al
    PTEN-AKT2 regulates mixed lineage liver cancer development and sensitizes cancer cells to TGFbeta treatment.
    Oncogene. 2026;45:4362-4376.
    PubMed         Abstract available
    
    

    
    PLoS One

22. OOMMEN TT, Philips CA, Theruvath AH, Ravindran R, et al
    Admission interleukin-6 as a time-limited, etiology-dependent prognostic signal in hospitalized cirrhosis - A frequentist and Bayesian cohort study.
    PLoS One. 2026;21:e0360005.
    PubMed         Abstract available
    
    
23. ZHANG X, Wang X, Li N, Han Q, et al
    Association of 5-hydroxytryptamine 3 receptor antagonists with prognosis in patients with advanced hepatocellular carcinoma: A propensity score-matched study.
    PLoS One. 2026;21:e0359798.
    PubMed         Abstract available
    
    
24. LIN L, Weng N, Lai H, Wu G, et al
    Integrated multi-omic analysis characterizes an IFNgamma-responsive-to-myeloid-suppressive immune continuum in immune-active hepatocellular carcinoma.
    PLoS One. 2026;21:e0359327.
    PubMed         Abstract available
    
    
25. SCHUTTE SL, Heidrich B, Wedemeyer H, Maasoumy B, et al
    Novel peritoneal catheters with silver particles lower rates of peritonitis in patients with cirrhosis and refractory ascites.
    PLoS One. 2026;21:e0359408.
    PubMed         Abstract available
    
    
26. ZUO Z, Yang C, Hu L, Ye X, et al
    Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease.
    PLoS One. 2026;21:e0357883.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. WU H, Shen X, Zhao T, Zhang H, et al
    Mechanotherapy enhances nanodrug uptake by overcoming the actin cytoskeleton damping effect.
    Proc Natl Acad Sci U S A. 2026;123:e2600686123.
    PubMed         Abstract available
    
    

    
    Radiology

28. DING W, Ji R, Pang C, Li J, et al
    Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis.
    Radiology. 2026;321:e260918.
    PubMed         Abstract available
    
    
29. SERAI SD, Pepin K, Chen J, Venkatesh SK, et al
    Standardizing Liver MR Elastography: Guidelines for Reliable Stiffness Measurement in Chronic Liver Disease.
    Radiology. 2026;321:e260974.
    PubMed         Abstract available
    
    
30. SHAFAAT O, Reis SP
    Implications for Hepatocellular Carcinoma Ablation beyond the Tumor Margin: An Early Career Perspective.
    Radiology. 2026;321:e262757.
    PubMed        
    
    

    
    Transplant Proc

31. LIU Y, Liu Y, Dai C, Gu M, et al
    A Kidney Transplant Patient Suffering From Multiple Colonic Ulcers and Hepatic Abscess: A Case Report and Literature Review.
    Transplant Proc. 2026 Oct 3:S0041-1345(26)00429.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum